Changes in Antimicrobial Resistance and Etiology of Blood Culture Isolates: Results of a Decade (2010–2019) of Surveillance in a Northern Region of Colombia

References

• Martinez RM, Wolk DM, Hayden RT, Wolk DM, Carroll KC, Tang Y-W. Bloodstream Infections. Microbiol Spectr. 2016;4(4). doi:10.1128/MICROBIOLSPEC.DMIH2-0031-2016
   Web of Science ®Google Scholar
• Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200–211. doi:10.1016/S0140-6736(19)32989-7
   PubMed Web of Science ®Google Scholar
• Goto M, Al-Hasan MN. Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin Microbiol Infect. 2013;19(6):501–509. doi:10.1111/1469-0691.12195
   PubMed Web of Science ®Google Scholar
• Mcalearney AS, Hefner JL. Getting to zero: goal commitment to reduce blood stream infections. Med Care Res Rev. 2015:1–20. DOI:10.1177/1077558715616028
   Web of Science ®Google Scholar
• Kraker De MEA, Jarlier V, Monen JCM, Heuer OE, Sande Van De N, Grundmann H. The changing epidemiology of bacteraemias in Europe: trends from the European antimicrobial resistance surveillance system. Clin Microbiol Infect. 2012;19(9):860–868. doi:10.1111/1469-0691.12028
   Web of Science ®Google Scholar
• Diekema DJ, Hsueh PR, Mendes RE, et al. The microbiology of bloodstream infection: 20-year trends from the SENTRY antimicrobial surveillance program. Antimicrob Agents Chemother. 2019;63(7). doi:10.1128/AAC.00355-19
   PubMed Web of Science ®Google Scholar
• Fisman D, Patrozou E, Carmeli Y, et al. Geographical variability in the likelihood of bloodstream infections due to gram-negative bacteria: correlation with proximity to the equator and health care expenditure. PLoS One. 2014;9(12):1–18. doi:10.1371/journal.pone.0114548
   Web of Science ®Google Scholar
• World Health Organization (WHO). WHO global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics; 2017. Available from: https://apps.who.int/iris/handle/10665/311820. Accessed September 29, 2022.
   Google Scholar
• World Health Organization. Thirteenth general programme of work, 2019–2023. Geneva; 2019. Available from: https://apps.who.int/%0Airis/bitstream/handle/10665/324775/WHO-PRP-18.1-eng.pdf,%0A. Accessed April 8, 2021.
   Google Scholar
• Agnew E, Dolecek C, Hasan R, et al. Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report; 2021. Available from: http://www.who.int/glass/resources/publications/early-implementation-report-2020/en/.
   Google Scholar
• Instituto Nacional de Salud. Vigilancia Por Laboratorio En Infecciones Asociadas a La Atención En Salud (IAAS) Colombia, Años 2012 [Laboratory surveillance of healthcare associated infections Colombia years 2012 to 2020]; 2021. Spanish. Available from: https://www.ins.gov.co/buscador-eventos/Informacin.delaboratorio/vigilancia-por-laboratorio-de-resistencia-antimicrobiana-en-iaas-en-colombia-año-2016-A-2020.pdf. Accessed September 29, 2022.
   Google Scholar
• Johnson A. Surveillance of antibiotic resistance. Philos Trans R Soc B Biol Sci. 2015;370(1670):1670. doi:10.1098/rstb.2014.0080
   Web of Science ®Google Scholar
• ReLAVRA/OPS. Red Latinoamericana y del Caribe de Vigilancia de la Resistencia a los Antimicrobianos [Latinoamerican and caribbean network for AMR surveillance] - ReLAVRA+. OPS/OMS 2012; 2021. Available from: https://www3.paho.org/hq/index.php?option=com_content&view=article&id=13682:. Accessed September 29, 2022.
   Google Scholar
• Rada AM, Hernández-Gómez C, Restrepo E, Villegas MV. Distribución y caracterización molecular de betalactamasas en bacterias Gram negativas en Colombia, 2001–2016. [Distribution and molecular characterization of beta-lactamases in gram negative bacteria in Colombia, 2001-2016] Biomédica. 2019;39:199–220. doi:10.7705/BIOMEDICA.V39I3.4351
   Google Scholar
• Clinical and Laboratory Standards Institute. CLSI: Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data. 4th ed. M39-A4; 2014.
   Google Scholar
• Wayne PA. Performance Standards for Antimicrobial Susceptibility Testing. M-100. 29th ed. Clinical and Laboratory Standards Institute. CLSI; 2020.
   Google Scholar
• Jin L, Zhao C, Li H, Wang R, Wang Q, Wang H. Clinical profile, prognostic factors, and outcome prediction in hospitalized patients with bloodstream infection: results from a 10-year prospective multicenter study. Front Med. 2021;8. doi:10.3389/fmed.2021.629671.
   Web of Science ®Google Scholar
• Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Cases from a prospective nationwide surveillance study. BSI US Hosp • CID; 2004: 179. Available from: https://academic.oup.com/cid/article/39/3/309/351413. Accessed September 29, 2022.
   Google Scholar
• Sader HS, Castanheira M, Streit JM, Flamm RK. Frequency of occurrence and antimicrobial susceptibility of bacteria isolated from patients hospitalized with bloodstream infections in United States medical centers (2015–2017). Diagn Microbiol Infect Dis. 2019;95(3):114850. doi:10.1016/j.diagmicrobio.2019.06.002
   PubMed Web of Science ®Google Scholar
• Morkel G, Bekker A, Marais BJ, Kirsten G, van Wyk J, Dramowski A. Bloodstream infections and antimicrobial resistance patterns in a South African neonatal intensive care unit. Paediatr Int Child Health. 2014;34(2):108–114. doi:10.1179/2046905513Y.0000000082
   PubMed Web of Science ®Google Scholar
• Spaulding AB, Watson D, Dreyfus J, et al. Epidemiology of bloodstream infections in hospitalized children in the United States, 2009–2016. Clin Infect Dis. 2019;69(6):995–1002. doi:10.1093/cid/ciy1030
   Web of Science ®Google Scholar
• Beekmann SE, Diekema DJ, Doern GV. Determining the clinical significance of coagulase-negative staphylococci isolated from blood cultures. Infect Control Hosp Epidemiol. 2005;26(6):559–566. doi:10.1086/502584
   PubMed Web of Science ®Google Scholar
• Finkelstein R, Fusman R, Oren I, Kassis I, Hashman N. Clinical and epidemiologic significance of coagulase-negative staphylococci bacteremia in a tertiary care university Israeli hospital. Am J Infect Control. 2002;30(1):21–25. doi:10.1067/mic.2002.118406
   PubMed Web of Science ®Google Scholar
• Pien BC, Sundaram P, Raoof N, et al. The clinical and prognostic importance of positive blood cultures in adults. Am J Med. 2010;123(9):819–828. doi:10.1016/j.amjmed.2010.03.021
   PubMed Web of Science ®Google Scholar
• Diekema DJ, Pfaller MA, Shortridge D, Zervos M, Jones RN. Twenty-year trends in antimicrobial susceptibilities among Staphylococcus aureus from the SENTRY Antimicrobial Surveillance Program. Open Forum Infect Dis. 2019;6(Suppl 1):S47–S53. doi:10.1093/ofid/ofy270
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Carvalhaes CG, Smith CJ, Diekema DJ, Castanheira M. Bacterial and fungal pathogens isolated from patients with bloodstream infection: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (2012–2017). Diagn Microbiol Infect Dis. 2020;97(2):115016. doi:10.1016/j.diagmicrobio.2020.115016
   PubMed Web of Science ®Google Scholar
• Salles MJC, Zurita J, Mejía C, et al. Resistant Gram-negative infections in the outpatient setting in Latin America. Epidemiol Infect. 2013;141(12):2459–2472. doi:10.1017/S095026881300191X
   PubMed Web of Science ®Google Scholar
• Cantón R, Coque TM. The CTX-M β-lactamase pandemic. Curr Opin Microbiol. 2006;9(5):466–475. doi:10.1016/j.mib.2006.08.011
   PubMed Web of Science ®Google Scholar
• Radice M, Power P, Di Conza J, et al. Early dissemination of CTX-M-derived enzymes in South America [3] (multiple letters). Antimicrob Agents Chemother. 2002;46(2):602–604. doi:10.1128/AAC.46.2.602-604.2002
   Web of Science ®Google Scholar
• García-Betancur JC, Appel TM, Esparza G, et al. Update on the epidemiology of carbapenemases in Latin America and the Caribbean. Expert Rev Anti Infect Ther. 2021;19(2):197–213. doi:10.1080/14787210.2020.1813023
   PubMed Web of Science ®Google Scholar
• Panamerican Health Organization. Magnitud y tendencias de la resistencia a los antimicrobianos en Latinoamérica. ReLAVRA 2014, 2015, 2016. Informe resumido [Magnitude and Trends of Antimicrobial Resistance in Latin America. ReLAVRA 2014, 2015, 2016. Summary Report]; 2020. Spanish. Available from: https://www.Paho.org/es/documentos/magnitud-tendencias-resistencia-antimicrobianos-latinoamerica-relavra-2014-2015-2016. Accessed October 8, 2022.
   Google Scholar